Advances in the synthesis and application of nanoparticles for drug delivery

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 4, 2015, Pages 494-508

  Park, Wooram ^a   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG INTERACTIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; SELF ASSEMBLY; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

CLINICAL APPLICATION; CONTINUOUS DEVELOPMENT; CONTROLLED SELF-ASSEMBLY; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY SYSTEM; NANOPARTICLE TECHNOLOGIES; NANOPARTICULATE SYSTEM; THERAPEUTIC EFFICACY;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA VACCINE; LIPOSOME; NANOPARTICLE; NUCLEIC ACID; PHOTOSENSITIZING AGENT; PLASMID DNA; POLYMER; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMEDICINE; CANCER THERAPY; CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HEALTH CARE; LYSOSOME; MOUSE; NANOMEDICINE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETICULOENDOTHELIAL SYSTEM; SOLID TUMOR; ANIMAL; CHEMISTRY; HUMAN; PHOTOCHEMOTHERAPY; PROCEDURES; THERANOSTIC NANOMEDICINE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NANOPARTICLES; PHOTOCHEMOTHERAPY; THERANOSTIC NANOMEDICINE;

EID: 84931571606     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1325     Document Type: Article

References (97)

1. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
2. Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995, 16:61-73.
3. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1-20.
4. Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. WIREs Nanomed Nanobiotechnol 2012, 4:219-233.
5. Chou LY, Ming K, Chan WC. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 2011, 40:233-245.
6. Ghosh Chaudhuri R, Paria S. Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications. Chem Rev 2011, 112:2373-2433.
7. Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 2012, 41:2545-2561.
8. Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev 2014, 43:744-764.
9. Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev 2013, 65:21-23.
10. Cho K, Wang X, Nie S, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.
11. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2012, 64:206-212.
12. Moghimi S, Porter C, Muir I, Illum L, Davis S. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991, 177:861-866.
13. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
14. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S, Bentolila LA, Li J, Rao J. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5:126-134.
15. Jain RK, Baxter LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988, 48:7022-7032.
16. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990, 50:4478-4484.
17. Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popović Z, Jain RK, Bawendi MG, Fukumura D. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A 2011, 108:2426-2431.
18. Tong R, Hemmati HD, Langer R, Kohane DS. Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. J Am Chem Soc 2012, 134:8848-8855.
19. Gruenberg J, Van der Goot FG. Mechanisms of pathogen entry through the endosomal compartments. Nat Rev Mol Cell Biol 2006, 7:495-504.
20. Varkouhi AK, Scholte M, Storm G, Haisma HJ. Endosomal escape pathways for delivery of biologicals. J Control Release 2011, 151:220-228.
21. Lee C-S, Park W, Park S-j, Na K. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. Biomaterials 2013, 34:9227-9236.
22. S-j P, Na K. The transfection efficiency of photosensitizer-induced gene delivery to human MSCs and internalization rates of EGFP and Runx2 genes. Biomaterials 2012, 33:6485-6494.
23. S-j P, Park W, Na K. Photo-activatable ternary complex based on a multifunctional shielding material for targeted shRNA delivery in cancer treatment. Biomaterials 2013, 34:8991-8999.
24. S-j P, Na K. Photo-mediated internalization of nanocomplex for effective gene delivery to adipose tissue-derived stem cells. Colloids Surf B Biointerfaces 2013, 112:177-185.
25. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
26. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med 2012, 63:185-198.
27. Bangham A. Liposomes: the babraham connection. Chem Phys Lipids 1993, 64:275-285.
28. Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 2010, 62:1052-1063.
29. Adiseshaiah PP, Hall JB, McNeil SE. Nanomaterial standards for efficacy and toxicity assessment. WIREs Nanomed Nanobiotechnol 2010, 2:99-112.
30. Preiss MR, Bothun GD. Stimuli-responsive liposome-nanoparticle assemblies. Expert Opin Drug Deliv 2011, 8:1025-1040.
31. Al-Jamal WT, Kostarelos K. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine 2007, 2:85-98.
32. Volodkin DV, Skirtach AG, Möhwald H. Near-IR remote release from assemblies of liposomes and nanoparticles. Angew Chem Int Ed 2009, 48:1807-1809.
33. Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(l-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 2005, 21:8852-8857.
34. Farokhzad OC, Jon S, Khademhosseini A, Tran T-NT, LaVan DA, Langer R. Nanoparticle-aptamer bioconjugates a new approach for targeting prostate cancer cells. Cancer Res 2004, 64:7668-7672.
35. Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, Farokhzad OC. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A 2008, 105:2586-2591.
36. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, Seo MH. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 2001, 72:191-202.
37. Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim S-B, Rha SY, Lee MY, Ro J. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 2008, 108:241-250.
38. Zha L, Banik B, Alexis F. Stimulus responsive nanogels for drug delivery. Soft Matter 2011, 7:5908-5916.
39. Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 2012, 64:866-884.
40. Kim KS, Park W, Hu J, Bae YH, Na K. A cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle. Biomaterials 2014, 35:337-343.
41. Stubbs M, Bashford C, Griffiths J. Understanding the tumor metabolic phenotype in the genomic era. Curr Mol Med 2003, 3:49-59.
42. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005, 5:325-329.
43. Lee CS, Park W, Jo YU, Na K. Charge-switchable, four-armed polymeric photosensitizer for photodynamic cancer therapy. Chem Commun 2014, 50:4354-4357.
44. Huh KM, Kang HC, Lee YJ, Bae YH. pH-sensitive polymers for drug delivery. Macromol Res 2012, 20:224-233.
45. Lee ES, Shin HJ, Na K, Bae YH. Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 2003, 90:363-374.
46. Na K, Bae Y. pH-sensitive polymers for drug delivery. In: Polymeric Drug Delivery Systems, vol. 148. Boca Raton: Taylor & Francis; 2005, 129.
47. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
48. Kim T, Hyeon T. Applications of inorganic nanoparticles as therapeutic agents. Nanotechnology 2014, 25:012001.
49. Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 2012, 41:2575-2589.
50. Park J, An K, Hwang Y, Park J-G, Noh H-J, Kim J-Y, Park J-H, Hwang N-M, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
51. Ling D, Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 2013, 9:1450-1466.
52. Kim J, Kim HS, Lee N, Kim T, Kim H, Yu T, Song IC, Moon WK, Hyeon T. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
53. Lee JE, Lee N, Kim T, Kim J, Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011, 44:893-902.
54. Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
55. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010, 148:135-146.
56. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
57. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002, 2:750-763.
58. Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000, 85:217-229.
59. Clond MA, Lee B-S, Jeffrey JY, Singer MB, Amano T, Lamb AW, Drazin D, Kateb B, Ley EJ, John SY. Reactive oxygen species-activated nanoprodrug of ibuprofen for targeting traumatic brain injury in mice. PLoS One 2013, 8:e61819.
60. Park W, Bae B-c, Kim Y-H, Na K. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci 2010, 40:367-375.
61. Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S, Langer RS, Farokhzad OC. Targeted nanoparticles for cancer therapy. Nano Today 2007, 2:14-21.
62. Nobs L, Buchegger F, Gurny R, Allémann E. Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem 2006, 17:139-145.
63. Nobs L, Buchegger F, Gurny R, Allémann E. Poly (lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting. Eur J Pharm Biopharm 2004, 58:483-490.
64. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 2011, 153:198.
65. Nichols JW, Bae YH. Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today 2012, 7:606-618.
66. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
67. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006, 6:535-545.
68. Park H, Na K. Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy. Biomaterials 2013, 34:6992-7000.
69. Park W, Park S-j, Na K. The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher. Biomaterials 2011, 32:8261-8270.
70. Lee SJ, Park K, Oh Y-K, Kwon S-H, Her S, Kim I-S, Choi K, Lee SJ, Kim H, Lee SG. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 2009, 30:2929-2939.
71. Ling D, Bae B-c, Park W, Na K. Photodynamic efficacy of photosensitizers under an attenuated light dose via lipid nano-carrier-mediated nuclear targeting. Biomaterials 2012, 33:5478-5486.
72. Park YI, Kim HM, Kim JH, Moon KC, Yoo B, Lee KT, Lee N, Choi Y, Park W, Ling D, et al. Theranostic probe based on lanthanide-doped nanoparticles for simultaneous in vivo dual-modal imaging and photodynamic therapy. Adv Mater 2012, 24:5755-5761.
73. B-c B, Na K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
74. Lee Y, Ishii T, Cabral H, Kim HJ, Seo JH, Nishiyama N, Oshima H, Osada K, Kataoka K. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. Angew Chem Int Ed 2009, 48:5309-5312.
75. Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 2008, 7:21-39.
76. Yan M, Du J, Gu Z, Liang M, Hu Y, Zhang W, Priceman S, Wu L, Zhou ZH, Liu Z. A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat Nanotechnol 2010, 5:48-53.
77. Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci 2007, 32:669-697.
78. Lee Y, Ishii T, Kim HJ, Nishiyama N, Hayakawa Y, Itaka K, Kataoka K. Efficient delivery of bioactive antibodies into the cytoplasm of living cells by charge-conversional polyion complex micelles. Angew Chem Int Ed 2010, 49:2552-2555.
79. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 2007, 9:833-842.
80. Miyata K, Nishiyama N, Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem Soc Rev 2012, 41:2562-2574.
81. Guo X, Huang L. Recent advances in nonviral vectors for gene delivery. Acc Chem Res 2011, 45:971-979.
82. Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J. Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010, 31:4129-4138.
83. Erlich RB, Werneck CC, Mourão PA, Linden R. Major glycosaminoglycan species in the developing retina: synthesis, tissue distribution and effects upon cell death. Exp Eye Res 2003, 77:157-165.
84. Oh Y-K, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009, 61:850-862.
85. Pathak A, Kumar P, Chuttani K, Jain S, Mishra AK, Vyas SP, Gupta KC. Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate - PEI nanoconstructs mediated tumor gene therapy. ACS Nano 2009, 3:1493-1505.
86. Park W, Park S-j, Na K. Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier. Colloids Surf B Biointerfaces 2010, 79:501-508.
87. Høgset A, Prasmickaite L, Selbo PK, Hellum M, Engesæter BØ, Bonsted A, Berg K. Photochemical internalisation in drug and gene delivery. Adv Drug Deliv Rev 2004, 56:95-115.
88. Selbo PK, Weyergang A, Høgset A, Norum O-J, Berstad MB, Vikdal M, Berg K. Photochemical internalization provides time-and space-controlled endolysosomal escape of therapeutic molecules. J Control Release 2010, 148:2-12.
89. Yoo D, Lee J-H, Shin T-H, Cheon J. Theranostic magnetic nanoparticles. Acc Chem Res 2011, 44:863-874.
90. Koo H, Huh MS, Sun I-C, Yuk SH, Choi K, Kim K, Kwon IC. In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 2011, 44:1018-1028.
91. Koo H, Huh MS, Ryu JH, Lee D-E, Sun I-C, Choi K, Kim K, Kwon IC. Nanoprobes for biomedical imaging in living systems. Nano Today 2011, 6:204-220.
92. Lindner D, Raghavan D. Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines. Br J Cancer 2009, 100:1287-1291.
93. Wang W, Cheng D, Gong F, Miao X, Shuai X. Design of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imaging. Adv Mater 2012, 24:115-120.
94. Ling D, Park W, Park S-j, Lu Y, Kim KS, Hackett MJ, Kim BH, Yim H, Jeon YS, Na K, et al. Multifunctional tumor pH-Sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. J Am Chem Soc 2014, 136:5647-5655.
95. Omidi Y. CNT nanobombs for specific eradication of cancer cells: a new concept in cancer theranostics. Bioimpacts 2011, 1:199-201.
96. Lee D-E, Koo H, Sun I-C, Ryu JH, Kim K, Kwon IC. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
97. Wang Y, Shim MS, Levinson NS, Sung HW, Xia Y. Stimuli-responsive materials for controlled release of theranostic agents. Adv Funct Mater 2014, 24:4206-4220.